key: cord-0069983-jzfbg7pa
authors: Javidfar, Jeffrey; Zaaqoq, Akram M.; Yashimata, Michael H.; Eschen, Greg; Jacobs, Jeffrey; Heinsar, Silver; Hayanga, Jeremiah W.; Peek, Giles; Arora, Rakesh
title: Venovenous extracorporeal membrane oxygenation in obese patients
date: 2021-10-28
journal: JTCVS Tech
DOI: 10.1016/j.xjtc.2021.08.048
sha: 5f2415f2d5c2245b245c5e16ada4fca155597c52
doc_id: 69983
cord_uid: jzfbg7pa

nan

Feature Editor's Note-The use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) has experienced broader adoption over the preceding decade for the management of respiratory failure. As experience with VV-ECMO has grown, VV-ECMO has been applied to more patients afflicted with a greater burden of comorbidities, which has been particularly evident during the global COVID-19 pandemic. One of the more common comorbidities is that of obesity. The use of VV ECMO in obese patients poses significant challenges and requires adoption of different techniques to achieve adequate respiratory support and successful outcomes. In this Invited Expert Technique article, Javidfar and colleagues review respiratory management and VV-ECMO techniques for application in obese patients. The authors discuss optimal respiratory management practices including use of esophageal pressure monitoring to assess lung pressures and special considerations in use of prone positioning. Optimal cannulation techniques are reviewed as well as techniques to obtain optimal ECMO flow, gas exchange and oxygenation, and facilitate airway management and physical therapy. Importantly, the authors review thresholds and situations in which conversion to veno-arterial ECMO might be necessary. Javidar and colleagues should be congratulated on a timely, insightful, and comprehensive review on the topic VV-ECMO for respiratory failure in obese patients and for providing an excellent guide to achieving optimal outcomes. Francis D. Pagani, MD, PhD

Historically, obesity was not considered a major risk factor for adverse outcomes in patients with acute respiratory distress syndrome (ARDS). Commonly extracorporeal membrane oxygenation (ECMO) survivability prediction scores (ie, Respiratory Extracorporeal Membrane Oxygenation Survival Prediction score) do not consider obesity as a risk factor. 1,2 Indeed, obesity typically decreased the risk of mortality. However, in patients with COVID-19, obesity (body mass index [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and severe obesity (body mass index >40) are considered risk factors for poor outcomes related to acute hypoxemic respiratory failure (Table 1) . 3, 4 Venovenous (VV) ECMO has been used increasingly in the management of ARDS secondary to severe acute respiratory failure coronavirus-2. Safe vascular cannulation and adequate blood flow generation through the ECMO circuit are potentially serious obstacles for health care teams caring for obese COVID-19 patients. We seek to provide an Q2 expert review of an approach to the obese patient requiring VV ECMO.

Obesity is characterized by anatomical and physiological alterations that negatively affect pulmonary and cardiovascular function in critically ill patients. Obese patients are disproportionately susceptible to hypoxemia from chronic ventilation/perfusion mismatch. 5 Increased chest wall mass and intra-abdominal pressure also contribute to a decrease in functional residual capacity. 6 This might lead to an increase in pulmonary vascular resistance over time. Furthermore, patients with class 2 and 3 obesity have a higher resting oxygen consumption. 7 To meet the increased oxygen demands and to perfuse the excess body mass, obese patients have increased cardiac output and blood volume. 8 In normotensive obese patients, elevated cardiac output is associated with low peripheral vascular resistance and increased left ventricular enddiastolic pressure. 9 Finally, patients are susceptible to obesity hypoventilation syndrome, obstructive sleep apnea, secondary pulmonary hypertension, and right ventricular failure. 10 

Mechanical ventilation in patients with class 2 and 3 obesity and ARDS should be approached in a different manner than patients with a normal habitus. 11 The higher intra-abdominal pressures of obese patients can be countered with the use of reverse Trendelenburg position, which contributes to a decrease in transpulmonary pressure (P tp ). It is also imperative to use the minimal fraction of inspired oxygen to achieve the required partial pressure of oxygen (PaO 2 ) of 55 to 80 mm Hg. Studies have shown that hyperoxemia is associated with increased mortality in critically ill patients. 12, 13 Especially for obese patients, hyperoxemia can exacerbate the already existing chronic inflammation associated with poor outcomes. 14 Obese patients with ARDS can be optimized with low tidal volume of 4 to 6 cc/kg on the basis of predicted body weight and plateau pressure<30 cm H 2 O. 15 However, it is important to emphasize that lung size does not change with body weight, and tidal volumes should not be on the basis of actual body weight. Lower driving pressures have been linked to improved survival in patients with ARDS. 16, 17 However, this benefit did not carry over in the obese population likely because of difficulties with accurate pressure measurements. 18 In patients with class 2 and 3 obesity, P tp can be most accurately calculated using esophageal pressure monitoring.

The compliance of the respiratory system represents the combined compliance of the chest wall and the lungs. In patients with class 2 and 3 obesity, a sizeable fraction of applied positive end-expiratory pressure (PEEP) may be diverted to lifting the heavier chest wall and overlying subcutaneous tissue off of the lungs with little actual effect on P tp . This might lead to mechanical ventilation-induced lung injury from repetitive opening and closing of alveoli at low lung volumes (atelectrauma). Conversely, the blind application of high levels of PEEP might result in alveolar overdistension at end inspiration (barotrauma), as well as adverse cardiovascular consequences (Table E1) .

The use of an esophageal balloon can effectively titrate PEEP to increase lung compliance and improve arterial oxygenation in patients with ARDS 19 (Figure 1 ). However, a definitive survival benefit has not yet been shown using this technique in patients with severe ARDS. 20 Two assumptions are inherent. Esophageal pressure equates with pleural pressure, and pleural pressure is uniform throughout the hemithorax. 21 After the esophageal balloon is correctly calibrated and positioned, P tp can easily be displayed on the ventilator monitor. This allows the bedside clinician to visually inspect the true pulmonary distending pressures at any given time. Applied PEEP is then titrated in 2-cm H 2 0 increments to maintain a P tp PEEP of > 0 cm H 2 O to mitigate against atelectrauma while ensuring the P tp plateau remains <20 cm H 2 O to avoid barotrauma (Table E2) .

Although the esophageal balloon Q3 has its limitations, in patients with class 2 and 3 obesity, it is reasonable to use it to optimize PEEP and PaO 2 before committing to VV ECMO.

Prone positioning improves oxygenation by enhancing ventilation/perfusion matching by providing a more homogenous distribution of P tp throughout the lungs. 22 It either directly enhances lung compliance or indirectly improves it by reducing body wall compliance. 23 In patients with severe ARDS, early proning is associated with reduced mortality. 24 Prone positioning in obese patients has showed an improved PaO 2 :fraction of inspired oxygen ratio without higher complication rates 25 ( Figure E1 ). Before proning, it is important to develop a bedside checklist and to have well-trained staff with clear assignment and roles. Obese patients might be exposed to pressure injuries so adhesive pads should be applied to forehead, chest, iliac crests, and knees. Also, special head support devices can reduce the incidence of skin ulceration of the face. Automated proning beds have the advantage of requiring fewer staff and can facilitate rapid return to supine position (Table E3) .

When managing the morbidly obese patient in whom conventional management is failing, ECMO support should be considered. The safe placement of the ECMO cannulas requires specific surgical expertise that can be beyond the capabilities of centers with lower ECMO case volume or experience. 26 It might be prohibitive if cannulation is being contemplated remotely at a satellite hospital (Table E4) .

There are general principles of cannulation for obese patients, particularly those with class 3 obesity. First, because of habitus, there is an alteration of anatomical landmarks. In these situations it is most beneficial to use 2-view, real-time ultrasound guidance to access the vessels. 27, 28 Because of the increased amount of soft tissue, the vessels tend to be deeper from the surface and vascular access might require longer access needles and sheaths. One might need to use steeper angles for vascular access and during percutaneous soft tissue dilation ( Figure 2 ). The risk of guide wire kinking during cannulation is increased. One must maintain a low threshold to exchange and use fresh and/or stiffer wires when needed. The latter requires image guidance to minimize risk of vessel injury or rupture, and can be placed using exchange catheters even at the bedside. To further mitigate against kinking of the wire, the proceduralist should keep the needle angle as shallow as possible when initially accessing the vessel. Using longer, more gently tapered silicone dilators might also be useful. To assist with safe cannula placement, a second point of image guidance in the form of radiograph and/or cardiac echo (transthoracic or transesophageal) should be used.

Last, using 2 cannulas has the theoretical advantage of offering increased ECMO flows while minimizing hemolysis. In the interest of maximizing flows, use as large of a drainage cannula as possible to avoid high venous pressures 29 (Table 2 ). This not only facilitates enough gas exchange initially to support an obese patient, but provides a buffer of excess flow that allows for diuresis later in the patient's ECMO management course ( Figure E1 ). Use of the largest available drainage cannula should be considered during initial cannulation. If additional flows are needed, a third cannula can be placed either in the remaining femoral vein or an upper body vein to allow for a "VVV" configuration with bicaval drainage (Figure 3 , A). Alternatively, the lungs can be bypassed with a venoarterialvenous (VAV) ECMO configuration. There are specific pros and cons to the various configurations of VV ECMO in the class 2 and 3 obese patient (Table 3 ). If partial cardiac support is required then VAV ECMO offers the added benefit of partial cardiac support (Table 4 ). Even with the use of ultrasound, accessing the cervical vessels might be challenging. The right internal jugular (IJ) vein tends to be the easiest site for peripheral cannulation in this population because it is anatomically in line with the superior vena cava. This can be for either a singlesite dual lumen cannula or as part of a femoral-IJ configuration. A dual lumen cannula has the benefit of requiring only a single vascular puncture, but should only be placed by experienced cannulators using the requisite image guidance to prevent vascular or cardiac injury. This necessitates the availability of image guidance in the intensive care unit or that the patient is stable enough for transportation to the operating room or catheterization lab. Maximum flows tend to be approximately 4.5 liters per minute (LPM), and this might be insufficient to support the class 2 and 3 obese patient in the acute phase of their ARDS. 30 However, a duallumen cannula has the advantages of obviating the need for a femoral cannula, which can facilitate patient mobilization, easier rehabilitation, and increase patient comfort. 31 Femoral cannulation, femoral-femoral, or femoral-IJ configuration can be used. Two cannulation sites have the advantage of greater flows due to enhanced drainage versus a single-site, dual-lumen cannula. However, a large pannus and significant amount of subcutaneous tissue can make femoral cannulation challenging. To mitigate against challenges such as kinking of guide wires and difficulties with serial dilation one should take care to meticulously retract the pannus in a secure fashion before prepping and draping.

The preferential use of the right groin might be advisable because the right femoral vein is anatomically more in line with the inferior vena cava. However, bifemoral cannulation can be performed safely at the bedside, and, if used with image guidance, offers a low risk of recirculation ( Figure 3, B) .

If the patient does not require high flows, IJ vein or left subclavian vein cannulation with a dual-lumen cannula might offer the advantage of obviating the need for a femoral cannula, facilitating mobilization and freeing up a peripheral venous access site (Figure 3 , C). The left subclavian vein has the added advantage of being further away from the tracheostomy site and less likely to be soiled by its secretions. Because of the anatomy and habitus, radiographic guidance should be routinely used for all duallumen cannulations.

The primary goal of VV ECMO is to provide adequate gas exchange and oxygenation while allowing the lungs time to recover. Oxygenation depends on rate of flow, hemoglobin concentration, oxygenator surface area, and the fraction of inspired oxygen of the gas flow. To maximize oxygen delivery, high ECMO flow (6-7 LPM) is needed, which is dependent on cannula size, position, and patient volume status. Elevating serum hemoglobin levels can increase blood oxygen content. 32 Finally, increasing oxygenator surface area by using 2 oxygenators in parallel can improve oxygenation and gas exchange. 33 The pharmacokinetics in obese patients receiving ECMO has not been wellstudied. However, the literature shows that differences in opioid and benzodiazepine requirements were not as great as initially predicted for obese versus nonobese patients receiving VV ECMO. 34 

Obese patients can be difficult to manage in the critical care setting. Prone positioning of obese patients receiving VV ECMO has specific pitfalls. Most concerning, are accidental decannulation, extubation, or removal of invasive lines from the patient. However, in experienced centers many of these complications tend to be avoided. 35 Proning patients receiving ECMO is also labor-intensive and can lead to staff injuries. Furthermore, proning obese patients receiving VV ECMO can increase intra-abdominal pressures and impair ECMO flows. Finally, as discussed previously, class 2 and 3 obese patients are at an increased risk of cannula kinking, skin breakdown, and pressure ulcer formation.

Tracheostomy in the ECMO population is considered safe. 36 After patients are receiving ECMO, each center should continue to follow its established protocols and guidelines for airway management including timing and surgical approach to tracheostomy. When possible, early tracheostomy should be considered. The use of extra-long tracheostomy tubes should be considered to minimize the risk of dislodgement, fistula formation, and tracheal injury. 37 

Patients with class 2 and 3 obesity who require VV ECMO are at particular risk for critical illness myopathy and muscle loss. Mobilization also poses a challenge. Practical risks include kinking of lower body cannulas due to the pannus as a result of the angle that the femoral cannula travels through the soft tissue. 38, 39 In instances in which 2 or more sites of cannulation are required, physical activity might be limited to bed exercises, such as active and passive range of motions activities. It is important to firmly secure the cannula and tubing to the skin with suture and attachment devices. Usually bed-based pedal bikes can be logistically prohibitive because of the habitus and ergonomics. Patients may sit up in a bed converted to the chair position. Tilt table beds specially designed for physical therapy allow for standing and weight-bearing. They can be used to build core strength without flexion at the hips.

It is easier to mobilize patients who can solely be supported using upper body dual-lumen cannula. 40, 41 As ECMO flow requirements decrease below 4 to 4.5 LPM, a patient can be converted to a dual-lumen cannula, and out of bed exercises can begin. This can include dangling, sit to stand, and then walking on portable treadmills. Patients can also strengthen their core by spending hours a day sitting in a chair. At the peak of their physical therapy training patients can walk laps in the intensive care unit (because they are usually off of isolation precautions by this point). Stationary bikes may also be used.

Patients with class 2 or 3 obesity tend to be hypercoagulable in part due to the higher inflammatory state. This, when possible, calls fora higher degree of anticoagulation. There is also a trend toward bivalirudin usage in lieu of heparin for daily anticoagulation management in VV ECMO patients. Intravenous bivalirudin has been associated with decreased number of ECMO circuit-related thrombotic events and decreased blood transfusions compared with unfractionated heparin drip. 42 In practice, this can still include a heparin bolus of 5000 to 8000 units for cannulation. The initial use of heparin is on the basis of practicality and availability in patients with emergency or remote cannulations. However, it is dosed at a higher level than for nonobese patients. For maintenance, patients can be transitioned to a bivalirudin drip with activated partial thromboplastin time (aPTT) monitoring. The dosing is managed with a nomogram with a starting aPTT goal of 60 to 80 seconds. Alternatively, a heparin drip with a Factor Xa or an aPTT monitoring nomogram can be used. The anticoagulation should be titrated depending on instance and severity of events such as intracranial bleeding, gastrointestinal bleeding, and bleeding from the naso/oro pharynx or tracheostomy site. Additional benefits of bivalirudin include a short half-life, easy monitoring, and avoidance of heparininduced thrombocytopenia and/or antithrombin III deficiency. All post-ECMO patients with class 2 or 3 obesity would benefit from 4-limb surveillance ultrasound examination, because some might need continued post ECMO anticoagulation. JTCVS Techniques c Volume -, Number -5   493  494  495  496  497  498  499  500  501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553   554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594  595  596  597  598  599  600  601  602  603  604  605  606  607  608  609  610  611  612  613 615  616  617  618  619  620  621  622  623  624  625  626  627  628  629  630  631  632  633  634  635  636  637  638  639  640  641  642  643  644  645  646  647  648  649  650  651  652  653  654  655  656  657  658  659  660  661  662  663  664  665  666  667  668  669  670  671  672  673  674  675   676  677  678  679  680  681  682  683  684  685  686  687  688  689  690  691  692  693  694  695  696  697  698  699  700  701  702  703  704  705  706  707  708  709  710  711  712  713  714  715  716  717  718  719  720  721  722  723  724  725  726  727  728  729  730  731  732  733  734  735 

The pre-and peri-ECMO phases are usually when patients with refractory respiratory failure are the most hemodynamically unstable. They usually have significant acid-base disarray, and can require high doses of multiple pressors and/or ionotropes. Maximal ventilator support might fail, which includes high PEEP levels that can diminish venous return. In this situation, patients are vulnerable to varying degrees of right heart failure that can be made worse by the physiologic changes associated with class 2 and 3 obesity. If significant hemodynamic instability is being experienced, additional right heart support can be derived from inhaled pulmonary vasodilators (such as nitric oxide and epoprostenol sodium) and/or ionotropes. In our experience in obese class 2 and 3 patients with isolated respiratory failure severe right heart failure is transient. Significant hemodynamic benefits can be derived from VV ECMO alone without directed mechanical support of the right heart. VV ECMO allows for a rapid correction of pH and improvement in pharmacokinetics because enzymes and medications tend to work optimally at a normal pH. As the ventilator is weaned further toward rest settings, a normalization of the previously very high PEEP improves venous return. Often after a brief period of VV ECMO, pressors, ionotropes, and the ventilator can all be weaned as the patient's hemodynamics stabilize.

However, if patients VV ECMO plus inhaled pulmonary vasodilator and ionotropes fail, then several mechanical options are available. The first would involve converting the patient from VV ECMO to VAV ECMO by adding a peripheral arterial limb. This would provide the mechanical benefit of unloading the right and left heart, but can be technically challenging in the class 2 and 3 obese patient. The arterial limb can be placed percutaneously or open in a femoral artery, but this is subject to all of the associated challenges of femoral venous cannulation including difficult access and kinking. Additionally, the patient would require a distal perfusion cannula placed into the ipsilateral superficial femoral artery. This can be particularly challenging to perform reliably at the bedside in an obese patient. In this situation, we recommend using image guidance such as ultrasound or preferably, an angiogram in a hybrid operating room or catheterization lab. Because of the depth of soft tissue required to be transversed and to prevent inadvertent dislodgement we suggest using an extra-long wire-reinforced catheter. Alternatively, a retrograde reperfusion cannula can be placed in the posterior tibial artery where the soft tissue tends to be less extensive. Other surgical options for an arterial limb include tunneled cannulation of a graft sewn onto the axillary or femoral artery. It would obviate the need for a distal perfusion cannula, but the tunneled graft and cannula can kink in the soft tissue of class 2 or 3 patients. In the axilla, there is also a potential risk of brachial plexus compression from a deep hematoma that was not detected because of the patient's habitus. Additional options include transjugular pulmonary artery cannulation. This can be via either a 2-site technique that includes femoral venous drainage or making use of the ProTek Duo (Liva Nova), which is a dual-lumen cannula commonly placed in the right IJ vein, which bypasses the right ventricle. This cannula can be technically Figure E2 ).

Patients with class 2 or 3 obesity initially receiving VV ECMO should continue to be ventilated with similar strategies outlined herein for the pre-ECMO phase. Reverse Trendelenburg bed positioning and use of an esophageal probe can optimize respiratory mechanics while accurately recreating rest settings per ARDS Net protocols. As lung recovery occurs, the sequence for weaning of the mechanical ventilator and ECMO should conform to the ECMO center's best practices. Specifically, if a center routinely manages VV ECMO patients without positive pressure ventilation, then the strategy can be applied to select patients with class 2 or 3 obesity. The potential advantages of liberating VV ECMO patients from mechanical ventilation include earlier mobilization, decreased sedation requirements, improved mentation, and improved respiratory muscle usage. 43 This would also apply to those with class 2 or 3 obesity. We would, however, caution against using these patients as the first cohort for trialing ECMO without a mechanical ventilator. Mobilizing patients with class 2 or 3 obesity while they are receiving ECMO can be rather challenging. Early tracheostomy could be a comprise by providing a protected airway while allowing for periods free from positive pressure ventilation.

Acute lung injury in the patients with class 2 and 3 obesity can be difficult to manage particularly as a patient progresses to ARDS. Ventilator optimization might involve the use of an esophageal probe to measure P tp 's and where feasible, proning patients should be considered before initiating VV ECMO. However, if respiratory failure is refractory to conventional means, then mechanical circulatory support is a reasonable option in appropriately resourced and experienced centers.

ECMO therapy for the class 2 and 3 obese patient population presents certain unique challenges that require thoughtful planning and meticulous execution of cannulation. Although ECMO cannulation can be a "routine" urgent procedure, it requires experienced cannulators with access to appropriate imaging. After ECMO is started, standard management practices might need to be adjusted to mitigate against mechanical and physiological challenges posed by obesity, including the need for increased flow. Mobilizing this patient population might be difficult, but it is possible and necessary to ensure a meaningful recovery.

For patients with severe morbid obesity VV ECMO should be considered an option in experienced hands. 

Worsening right heart failure on VV ECMO 1103  1104  1105  1106  1107  1108  1109  1110  1111  1112  1113  1114  1115  1116  1117  1118  1119  1120  1121  1122  1123  1124  1125  1126  1127  1128  1129  1130  1131  1132  1133  1134  1135  1136  1137  1138  1139  1140  1141  1142  1143  1144  1145  1146  1147  1148  1149  1150  1151  1152  1153  1154  1155  1156  1157  1158  1159  1160  1161  1162  1163   1164  1165  1166  1167  1168  1169  1170  1171  1172  1173  1174  1175  1176  1177  1178  1179  1180  1181  1182  1183  1184  1185  1186  1187  1188  1189  1190  1191  1192  1193  1194  1195  1196  1197  1198  1199  1200  1201  1202  1203  1204  1205  1206  1207  1208  1209  1210  1211  1212  1213  1214  1215  1216  1217  1218  1219  1220  1221  1222  1223 1225  1226  1227  1228  1229  1230  1231  1232  1233  1234  1235  1236  1237  1238  1239  1240  1241  1242  1243  1244  1245  1246  1247  1248  1249  1250  1251  1252  1253  1254  1255  1256  1257  1258  1259  1260  1261  1262  1263  1264  1265  1266  1267  1268  1269  1270  1271  1272  1273  1274  1275  1276  1277  1278  1279  1280  1281  1282  1283  1284  1285   1286  1287  1288  1289  1290  1291  1292  1293  1294  1295  1296  1297  1298  1299  1300  1301  1302  1303  1304  1305  1306  1307  1308  1309  1310  1311  1312  1313  1314  1315  1316  1317  1318  1319  1320  1321  1322  1323  1324  1325  1326  1327  1328  1329  1330  1331  1332  1333  1334  1335  1336  1337  1338  1339  1340  1341  1342  1343  1344  1345 One caregiver raises the sling bar until there is tension in the straps, then the team confirms that all the required loops are secure in the sling bar Perfusionist is responsible for visualizing cannulas throughout the turn Ensure the team member at the head of the bed is responsible for initiating the turn maneuver via a verbal countdown, as well as securing the patients ETT and head throughout the maneuver. At this point, the patient is ready to be lifted On the count of 3, the caregiver on the side from which the patient is being turned away will operate the lift, while the other caregiver(s) monitor the lines and patient's response

The caregiver at the head of bed will monitor and support the patient's head and airway. Caregivers at the foot of the bed are responsible for managing the LEs Upon lifting, the lift equipment will begin to rotate the patient to the side. The lift movement is slow and controlled

Lift the patient high enough so they easily slide, but do not lift the patient fully off the bed. Slide patient to opposite side from which you are turning so they are centered when proned. The team should continue to manage tubing and lines as patient is being lowered Return ICU bed to normal mattress setting Before exiting the room, intensivist/APP to monitor vitals and assess patient's tolerance to position When returning the patient to the supine position, simply reconnect the ceiling lift to the bar in the same manner as when proning and follow the same procedures described above to return to supine position Please note, when returning the patient from prone to supine, ceiling lift used in lower portion of body should be inserted with care to avoid disturbing/ dislodging femoral cannula access Z-Flo is from M€ olnlycke Health Care. LE, ---; ETT, ---; ICU, intensive care unit; APP Q8 , ---.

JTCVS Techniques c -2021   1347  1348  1349  1350  1351  1352  1353  1354  1355  1356  1357  1358  1359  1360  1361  1362  1363  1364  1365  1366  1367  1368  1369  1370  1371  1372  1373  1374  1375  1376  1377  1378  1379  1380  1381  1382  1383  1384  1385  1386  1387  1388  1389  1390  1391  1392  1393  1394  1395  1396  1397  1398  1399  1400  1401  1402  1403  1404  1405  1406  1407   1408  1409  1410  1411  1412  1413  1414  1415  1416  1417  1418  1419  1420  1421  1422  1423  1424  1425  1426  1427  1428  1429  1430  1431  1432  1433  1434  1435  1436  1437  1438  1439  1440  1441  1442  1443  1444  1445  1446  1447  1448  1449  1450  1451  1452  1453  1454  1455  1456  1457  1458  1459  1460  1461  1462  1463  1464  1465  1466  1467  1468 EDI 5.6.0 DTD XJTC960_proof 15 November 2021 6:12 pm ce CC JTCVS Techniques c Volume -, Number -13   1469  1470  1471  1472  1473  1474  1475  1476  1477  1478  1479  1480  1481  1482  1483  1484  1485  1486  1487  1488  1489  1490  1491  1492  1493  1494  1495  1496  1497  1498  1499  1500  1501  1502  1503  1504  1505  1506  1507  1508  1509  1510  1511  1512  1513  1514  1515  1516  1517  1518  1519  1520  1521  1522  1523  1524  1525  1526  1527  1528  1529   1530  1531  1532  1533  1534  1535  1536  1537  1538  1539  1540  1541  1542  1543  1544  1545  1546  1547  1548  1549  1550  1551  1552  1553  1554  1555  1556  1557  1558  1559  1560  1561  1562  1563  1564  1565  1566  1567  1568  1569  1570  1571  1572  1573  1574  1575  1576  1577  1578  1579  1580  1581  1582  1583  1584  1585  1586  1587  1588  1589 14 JTCVS Techniques c -2021   1591  1592  1593  1594  1595  1596  1597  1598  1599  1600  1601  1602  1603  1604  1605  1606  1607  1608  1609  1610  1611  1612  1613  1614  1615  1616  1617  1618  1619  1620  1621  1622  1623  1624  1625  1626  1627  1628  1629  1630  1631  1632  1633  1634  1635  1636  1637  1638  1639  1640  1641  1642  1643  1644  1645  1646  1647  1648  1649  1650  1651   1652  1653  1654  1655  1656  1657  1658  1659  1660  1661  1662  1663  1664  1665  1666  1667  1668  1669  1670  1671  1672  1673  1674  1675  1676  1677  1678  1679  1680  1681  1682  1683  1684  1685  1686  1687  1688  1689  1690  1691  1692  1693  1694  1695  1696  1697  1698  1699  1700  1701  1702  1703  1704  1705  1706  1707  1708  1709  1710  1711 

Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) Score

Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis

Centers for Disease Control and Prevention. Defining adult overweight & obesity. Accessed

People with certain medical conditions

Regional distribution of pulmonary ventilation and perfusion in obesity

The effects of body mass index on lung volumes

The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest

Estimating blood volume in obese and morbidly obese patients

Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function

Pulmonary hypertension in obesity-hypoventilation syndrome

ARDS in obese patients: specificities and management

The association between supraphysiologic arterial oxygen levels and mortality in critically ill patients. A multicenter observational cohort study

Association between arterial hyperoxia and mortality in critically ill patients: a systematic review and metaanalysis

Effects of hyperoxia on oxygen-related inflammation with a focus on obesity

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome

Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials

Driving pressure and survival in the acute respiratory distress syndrome

Impact of the driving pressure on mortality in obese and non-obese ARDS patients: a retrospective study of 362 cases

Mechanical ventilation guided by esophageal pressure in acute lung injury

Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial

The promises and problems of transpulmonary pressure measurements in acute respiratory distress syndrome

Effects of prone position and positive end-expiratory pressure on lung perfusion and ventilation

Prone position improves lung mechanical behavior and enhances gas exchange efficiency in mechanically ventilated chronic obstructive pulmonary disease patients

Prone positioning in severe acute respiratory distress syndrome

Feasibility and effectiveness of prone position in morbidly obese patients with ARDS: a case-control clinical study

Pitfalls in percutaneous ECMO cannulation

Extremely obese patients treated with venovenous ECMO-an intensivist's challenge

Veno-venous extracorporeal membrane oxygenation in obese surgical patients with hypercapnic lung failure

Class III obesity is not a contraindication to venovenous extracorporeal membrane oxygenation support

Direct complications of the Avalon bicaval dual-lumen cannula in respiratory extracorporeal membrane oxygenation (ECMO): single-center experience

Physiology of gas exchange during ECMO for respiratory failure

Parallel circuits for refractory hypoxemia on venovenous extracorporeal membrane oxygenation

Opioid and benzodiazepine requirements in obese adult patients receiving extracorporeal membrane oxygenation

Complications of prone positioning during extracorporeal membrane oxygenation for respiratory failure: a systematic review. Respir Care

Tracheostomy is safe during extracorporeal membrane oxygenation support

Postoperative complications in obese patients after tracheostomy

Safety and feasibility of early physical therapy for patients on extracorporeal membrane oxygenator: University of Maryland Medical Center experience

Feasibility and safety of early physical therapy and active mobilization for patients on extracorporeal membrane oxygenation

The challenges faced with early mobilization of patients on extracorporeal membrane oxygenation

Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study

Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: heparin versus bivalirudin

Characteristics of patients managed without positive pressure ventilation while on extracorporeal membrane oxygenation for acute respiratory distress syndrome

The authors reported no conflicts of interest.The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.Illustrations were graciously provided by Andy Mattlock, Department of Surgery, Emory School of Medicine. The authors thank the Washington MedStar Healthsystem ECMO team and the Emory Healthcare ECMO team for their checklists and protocols.